Tag: Cholesterol: Dietary
Low, High HDL Linked to Risk for Age-Related Macular Degeneration
LPA was identified as a novel single nucleotide polymorphism that is associated with increased risk for AMD
Lipoprotein(a) Levels Tied to Increased Risk of Recurrent Atherosclerotic CVD Events
Deleterious effect of lipoprotein(a) ≥180 nmol/L possibly mitigated by high-impact LDL-cholesterol-lowering therapy
Combination Lipid-Lowering Therapy Linked to Greater Drop in LDL-C
Greater reduction seen in LDL-C; reductions also seen in all-cause mortality, major adverse CV events, stroke incidence
Olpasiran Leads to Significant Reduction in Oxidized Phospholipids
Olpasiran leads to significant and sustained reduction in OxPL on apolipoprotein B
Decline in BMI, Waist Circumference Seen in Decade Before Dementia
Dementia cases had lower BMI and waist circumference and faster declines; HDL levels generally higher predementia
Elevated HDL Cholesterol Linked to Increased Risk for Glaucoma
Elevated LDL cholesterol, total cholesterol, triglycerides linked to reduced risk for glaucoma
Variability in Total Cholesterol, LDL Cholesterol Linked to Dementia
Higher variability also linked to cognitive impairment with no dementia and with faster decline in global cognition, episodic memory
HDL Cholesterol May Protect Against Brain Atrophy
Association seen between HDL cholesterol and greater grey matter volume in midlife independent of traditional risk factors
Lower Levels of Total Cholesterol Seen in More Recent Birth Cohorts
More recent cohorts also have lower levels of fasting triglycerides, but higher levels of fasting glucose
AHA: Muvalaplin Reduces Lipoprotein(a) Levels in Individuals With Cardiovascular Risk
Reduction in levels seen using an intact lipoprotein(a) assay and apolipoprotein(a)-based assay
